University College London at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University College London brings 12 presentations to ASH 2026 in New Orleans. Its research centres on CAR T-cell engineering and immune responses in myeloma. It includes a way to make allogeneic CAR-T cells without gene editing and long-read sequencing in a myeloma trial.
| Organization | ASH 2026 Attendance |
|---|---|
University College London London, United Kingdom | |
Public research university in London with large medical and life-sciences faculties. | Symposium Fri Dec 11 3:00pm–6:00pm Medical Crossfire®: Strategic Sequencing in ALL — From Asparaginase to Cellular Therapy in an MRD-Driven Era Ordering acute lymphoblastic leukemia therapies, from asparaginase to bispecifics and CAR-T, guided by sensitive residual disease testing. Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Session Sun Dec 13 9:30am–10:45am Through Space and Time: Spatiotemporal Organization of Haematopoiesis in Health and Disease Blood stem cells do not share one uniform niche, and location, chromosome dosage, and body-wide feedback shape them in development, disease, and aging. Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 10:30am–12:00pm Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University College London
Tell us what you sell and we’ll find the people at University College London most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction